We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCC icon
326
Warrior Met Coal
HCC
$4.45B
$2.57M 0.02%
+150,000
New +$2.61M
V icon
327
Visa
V
$688B
$2.56M 0.02%
27,342
-33,428
-55% -$3.1M
JNCE
328
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.56M 0.02%
182,422
+44,866
+33% +$960K
ARGX icon
329
argenx
ARGX
$54.3B
$2.53M 0.02%
+119,146
New +$2.48M
CUBE icon
330
CubeSmart
CUBE
$9.5B
$2.47M 0.02%
+102,758
New +$2.6M
LINC icon
331
Lincoln Educational Services
LINC
$1.36B
$2.43M 0.02%
784,912
+454,584
+138% +$1.39M
SAVE
332
DELISTED
Spirit Airlines, Inc.
SAVE
$2.42M 0.02%
46,892
+4,577
+11% +$250K
ATRA icon
333
Atara Biotherapeutics
ATRA
$76.9M
$2.4M 0.02%
6,870
-6,447
-48% -$2.48M
LJPC
334
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.4M 0.02%
80,583
+5,583
+7% +$160K
ELVT
335
DELISTED
Elevate Credit, Inc.
ELVT
$2.35M 0.02%
+297,046
New +$2.33M
SPG icon
336
Simon Property Group
SPG
$72.9B
$2.34M 0.02%
14,456
-22,735
-61% -$3.7M
SNV
337
DELISTED
Synovus
SNV
$2.33M 0.02%
+52,771
New +$2.22M
APRN
338
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$2.33M 0.02%
+1,389
New +$2.42M
TIG
339
DELISTED
TiGenix American Depositary Shares
TIG
$2.33M 0.02%
103,487
-54,651
-35% -$965K
GLPI icon
340
Gaming and Leisure Properties
GLPI
$12.4B
$2.33M 0.02%
61,752
-635,463
-91% -$22.8M
VRNS icon
341
Varonis Systems
VRNS
$4.98B
$2.33M 0.02%
+187,620
New +$2.15M
SOS
342
SOS Limited
SOS
$14.2M
$2.29M 0.02%
+53
New +$2.79M
TOVX icon
343
Theriva Biologics
TOVX
$10.3M
$2.28M 0.02%
461
-14
-3% -$69.7K
NH
344
DELISTED
NantHealth, Inc
NH
$2.26M 0.02%
35,588
-1,079
-3% -$59.8K
LLL
345
DELISTED
L3 Technologies, Inc.
LLL
$2.23M 0.02%
+13,375
New +$2.23M
BOOT icon
346
Boot Barn
BOOT
$4.88B
$2.22M 0.02%
313,667
-129,184
-29% -$1.11M
PACB icon
347
Pacific Biosciences
PACB
$404M
$2.14M 0.02%
+600,000
New +$2.42M
FOGO
348
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
$2.1M 0.02%
+151,311
New +$2.24M
FLS icon
349
Flowserve
FLS
$10.1B
$2.1M 0.02%
+45,263
New +$2.18M
BY icon
350
Byline Bancorp
BY
$1.79B
$2M 0.02%
+100,000
New +$2M
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.